Life science company Addlife has reported a decrease in revenue for the fourth quarter compared to the same period last year. Adjusted operating profit (EBITA) also declined. However, the board is proposing a higher dividend.
Revenue fell by 3.0 percent to SEK 2,733 million (2,818). Organic sales growth was 1 percent (9).
Gross profit amounted to SEK 1,041 million (1,044), with a gross margin of 38.1 percent (37.0).
EBITA reached SEK 497 million (346), with an EBITA margin of 18.2 percent (12.3).
Adjusted EBITA was SEK 339 million (346).
Operating profit totaled SEK 393 million (229), with an operating margin of 14.4 percent (8.1).
Profit before tax was SEK 343 million (150).
Net profit after tax came to SEK 260 million (94), or SEK 2.12 per share (0.76).
The ordinary dividend proposed is SEK 1.50 per share (0.75).
Cash flow from operating activities amounted to SEK 888 million (666).
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
